Article
Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.
Scandinavian journal of infectious diseases - 1 Jan 2007
Di Giambenedetto Simona, Bacarelli Alessanra, Pinnetti Carmen, Colafigli Manuela, Prosperi Mattia, Gatti Giorgio, Cauda Roberto, De Luca Andrea
Abstract excerpt
The aim of this study was to establish the prevalence and predictors of genotypic resistance of HIV-1 to lopinavir and fosamprenavir from patients failing protease inhibitors (PI)-based regimens. We selected 643 HIV-1-infected patients with available treatment history who underwent genotypic resistance assays for virological failure from a clinical site and from the Stanford database. According to the genotypic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.